Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 019693
Company: LILLY

Products on NDA 019693

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DECABID	INDECAINIDE HYDROCHLORIDE	EQ 50MG BASE	TABLET, EXTENDED RELEASE;ORAL	Discontinued	None	No	No
DECABID	INDECAINIDE HYDROCHLORIDE	EQ 75MG BASE	TABLET, EXTENDED RELEASE;ORAL	Discontinued	None	No	No
DECABID	INDECAINIDE HYDROCHLORIDE	EQ 100MG BASE	TABLET, EXTENDED RELEASE;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 019693

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/29/1989	ORIG-1	Approval	Type 1 - New Molecular Entity	STANDARD		Label is not available on this site.